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Emergency departments (EDs) face several challenges in maintaining consistent quality care in the face of steadily
increasing public demand. Improvements in the survival rate of critically ill patients in the ED are directly related to
the advancement of early recognition and treatment. Frequent episodes of overcrowding and prolonged waiting
times force EDs to operate beyond their capacity and threaten to impact upon patient care. The objectives of this
review are as follows: (a) to establish overcrowding as a threat to patient outcomes, person-centered care, and public
safety in the ED; (b) to describe scenarios in which point-of-care testing (POCT) has been found to ameliorate factors
thought to contribute to overcrowding; and (c) to discuss how POCT can be used directly, and indirectly, to expedite
patient care and improve outcomes. Various studies have shown that overcrowding in the ED has profound effects on
operational efficiency and patient care. Several reports have quantified overcrowding in the ED and have described a
relationship between heightened periods of overcrowding and delays in treatment, increased incidence of adverse
events, and an even greater probability of mortality. In certain scenarios, POCT has been found to increase the number
of patients discharged in a timely manner, expedite triage of urgent but non-emergency patients, and decrease delays
to treatment initiation. This review concludes that POCT, when used effectively, may alleviate the negative impacts of
overcrowding on the safety, effectiveness, and person-centeredness of care in the ED.Introduction
Emergency departments (EDs) face a number of important
challenges in the modern health-care environment.
Simultaneously confronted with decreasing hospital
resources and growing public demand, EDs frequently
experience prolonged waiting times and extended periods
of overcrowding. Minimizing the delay between the onset
of symptoms and the initiation of therapy is critical to
improving outcomes for critically ill patients. Overcrowding
forces EDs to operate beyond their capacity and commonly
results in delays in diagnosis and treatment, potentially
impacting upon patient care. The impact of overcrowding
on public health and quality of care in the ED has received
national attention, prompting urgent calls for reform [1].
Consequently, there exists a critical and urgent need
for methods to enhance patient flow in order to lessen the* Correspondence: martin.schilling@lio.se
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overall quality of emergency care.
Point-of-care testing (POCT) provides physicians with
rapid results for many commonly ordered tests. The
implementation of POCT in an ED setting has been
suggested as a means to increase timely discharge rates,
shorten length of stay, and increase patient throughput.
When used in appropriate scenarios, POCT could be an
effective tool to minimize the time-to-treatment initiation
and to improve patient outcomes. This review will discuss
the problem of overcrowding, stressing its impact on
patient safety and care. Relevant examples from the
literature will be discussed, highlighting specific scenarios
in which POCT has been shown to expedite patient care
and to impact patient outcomes positively. As with any
new tool, identifying the opportunities in which that tool
can be most effectively used is a critical first step.Central Ltd. The licensee has exclusive rights to distribute this article, in any
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Overcrowding in the emergency department
Overcrowding is a global problem with a multitude of
negative consequences on efficiency and quality of care
[2]. Metrics of overcrowding and quality indicators in the
ED community vary greatly. Common definitions include
an increase in waiting and processing time, a lack of bed
capacity in the ED, a general perception of being rushed
by emergency physicians and staff, increased ambulance
diversions, and increased frequency of patients leaving the
ED without being seen [3].
Overcrowding can have a significant impact on the
timeliness and quality of care in the ED. Prolonged waiting
times and overcrowding have been associated with
substantial delays in the administration of antibiotics [4]
and pain medication [5]. Several studies have reported a
relationship between overcrowding in the ED and mortality
[6,7]. One retrospective study examined data from three
metropolitan hospitals over the course of a 3-year period in
Australia [7]. Using high hospital and bed occupancy
rates in the ED to quantify periods of overcrowding,
the researchers evaluated the impact of overcrowding
on the incidence of patient mortality on days 2, 7, and 30.
The results show a significant linear relationship between
overcrowding and mortality, and an estimated 120
deaths per year are hypothesized to be associated with
overcrowding. Another retrospective cohort study evaluated
data from all EDs in the greater Ontario area over the
course of a 5-year period [6]. Here, length of stay in the ED
was used to define overcrowding. A significantly greater risk
of death was found with increasing length of stay in the ED.
The overall severity of these effects on patient outcomes
suggests that overcrowding can justifiably be regarded
as issues of public health and safety rather than simply a
problem of ED efficiency.
A commonly cited reason for overcrowding is the
boarding of admitted patients in the ED when hospital
beds are unavailable [8]. Financial pressures make a
significant increase in hospital bed capacity as a solution




Single draw 30 30
Serial draw 43 43
hCG (urine) 95.3 100
hCG (blood) 95.8 100
D-dimer 83.3 100
100 100
CKMB, creatine kinase-MB; cTnT, cardiac troponin T; hCG, human chorionic gonadotand optimizing existing clinical pathways suggest a more
practicable approach. For example, ensuring an efficient
and rapid triage service can efficiently help to reduce
overcrowding in the ED [9]. Increasing the speed at
which low-risk and non-emergent patients are identified
will reduce downstream burdens, freeing up time for
emergency physicians to spend on more critically ill
or time-sensitive patients. Additionally, the rapid identifica-
tion of high-risk patients will decrease delays in treatment
initiation, potentially improving outcomes and shortening
overall length of stay.
Point-of-care testing
POCT refers to any diagnostic test administered outside
the central laboratory at or near the location of the patient.
In the past, the size and complexity of equipment required
to perform medical testing required a centralized hospital
laboratory. With advances in technology, it has become
increasingly possible to perform common clinical investiga-
tions outside of the laboratory at the point of care with a
reasonable level of accuracy (Table 1). The primary advan-
tages provided by POCT devices are increased portability
and speed. Using POCT, caregivers can perform, analyze,
obtain, and act on test results at the bedside in a matter of
minutes, significantly faster than if samples were sent out
to a central laboratory. If used effectively, POCT has the
potential to decrease delays to treatment initiation, increase
ED efficiency, influence patient care positively, and alleviate
the negative effects of overcrowding.
Numerous reports highlight decreases in turnaround
times (TATs) for test results with POCT in an emergency
setting [10,14]. One study compared TATs between POCT
and laboratory testing when a tube transport system was
implemented for the rapid transport of samples. Even
under circumstances that sought to minimize sample
transit times, POCT results were available an average of
46 minutes earlier than from the central laboratory [15].
Several studies evaluating point-of-care pregnancy testing in
the ED found that, regardless of whether ED staff evaluated
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yield sufficiently sensitive results faster than if samples
were sent to a central laboratory [11] as processing and
handling delays inherently extended laboratory TATs.
Current literature shows that the real-life impact of
POCT in the ED can vary greatly. The magnitude of the
effect POCT has on patient care and on efficiency shows
a strong dependency on the clinical context. Rapid TATs
for test results are most beneficial in cases in which (a)
delays in treatment of at least 1 hour can have significant
effects on outcomes and (b) delays in test results are the
primary determining factor holding up patient manage-
ment decisions. Interestingly, recent evidence suggests
that POCT can add value when used at the pre-hospital
level [16-18]. The following sections examine several
instances in which evidence supports the advantages
of implementing POCT in EDs.
Acute coronary syndrome
Patients presenting with symptoms of acute coronary syn-
drome (ACS) represent a sizable proportion of total
attendees in the ED. Approximately 70% of patients who
are admitted to the ED with suspicion of ACS are later ruled
out after further investigation [19]. Conversely, a non-trivial
number of patients with ACS are mistakenly discharged
home from the ED, resulting in avoidable patient mortality.
Clearly, a means of rapidly and accurately assessing
risk status in suspected patients with ACS would benefit
efficiency of the ED, patient care, and outcomes.
Biochemical evaluation of ACS with cardiac biomarkers,
specifically cardiac troponins (Tns), is becoming increas-
ingly common [20] and has proven to be a sensitive indi-
cator of myocardial injury [21]. Current guidelines suggest
that Tn measurements be made available to physicians
within 30 minutes of sample collection [20], and delays in
treatment are commonly associated with an increased
probability of adverse outcomes [22,23]. Disruptions
in laboratory processing times during periods of over-
crowding can negatively impact patient care and further
strain ED resources. Several available POCT technologies
exist for cardiac TnI testing with TATs of not more than
20 minutes [24,25]. In one report, the time delay between
blood draw and physician review was 42.1 minutes shorter
when POCT was used, compared with samples that were
sent to a central laboratory [26]. A rapid rule-out protocol
using a combination of high-sensitivity cardiac TnI testing,
risk score, and electrocardiogram was recently shown to be
safe and effective in identifying low-risk patients [27].
POCT has been shown to increase the speed at which
positive cases of ACS are accurately identified [16,28].
Importantly, these gains in diagnostic speed have been
found to translate into decreased times to percutaneous
coronary intervention and related treatment initiation
[14,28]. A number of studies have documented the impactof cardiac biomarker POCT on measures of ED efficiency.
The rapid TATs provided by POCT have universally been
found to reduce the average length of stay in the ED or
hospital [29,30]. A UK multicenter randomized controlled
study evaluated the performance of POCT for cardiac
biomarkers on patients with suspected myocardial infarc-
tion [31]. The researchers showed a 20% greater discharge
rate during the initial evaluation process when POCT was
performed. However, a follow-up study evaluating the
financial implications of POCT found variable results
[32]. A separate study evaluating the use of B-type
natriuretic peptide in patients presenting with dyspnea
found substantial cost savings with POCT [33], suggesting
that the impact on overall costs can vary greatly among
institutions. Although there is little direct evidence
that POCT in ACS results in superior outcomes [34],
an argument can be made that increased efficiency in the
ED will indirectly benefit patient care by alleviating the
negative effects of overcrowding.
Venous thromboembolic disease
Venous thromboembolic disease (VTD), including pulmon-
ary embolism and deep venous thrombosis, can be a serious
and potentially life-threatening condition. The mortality
rates in patients with pulmonary embolism can be high, yet
symptoms are often mild and easy to miss [35]. Therefore,
the availability of methods for the accurate identification of
patients with suspected VTD is critically important.
Risk assessment for VTD first divides patients into
low-risk and high-risk subgroups. The large majority
(~70%) of patients fall into the low-risk category and often
are tested for D-dimer, a fibrin degradation product formed
as a result of fibrinolysis or clot degradation. It has been
shown that, in patients with a Wells score of not more than
4, a negative D-dimer result can be used to safely rule out
deep venous thrombosis, eliminating the need to waste time
and resources on further testing [36,37]. Various POCT
devices exist for D-dimer with negative predictive values
higher than 98% [38]. Evaluation of these devices in an ED
setting found pronounced effects on TATs and measures of
efficiency. One study evaluated the effect of POCT on the
time to D-dimer results from triage in an emergency setting
[12]. The researchers found a median difference of
101.5 minutes between groups, with POCT providing
significantly faster results than traditional laboratory testing.
Another study compared performance of the ED before
and after implementation of a whole-blood rapid D-dimer
POCT device [13]. Researchers found that, following POCT,
mean length of stay in the ED decreased by approximately
1 hour and hospital admission rates dropped by 14%.
Severe sepsis
Sepsis is a life-threatening disease that arises when the
body’s response to infection injures its own organs and
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care, sepsis remains the primary cause of death from
infection and is one of the leading causes of death in
the world [39]. The clinical signs and symptoms of
sepsis (tachycardia, tachypnea, and pyrexia) are generally
very non-specific, making it difficult to identify patients
with sepsis at an earlier stage and to treat them in a timely
manner. Delays in treatment can have a profound negative
effect on outcomes. Therefore, an accurate and immediate
means of identifying patients with severe sepsis is critically
important for minimizing delays to resuscitation and
maximizing clinical benefits.
Elevated blood lactate levels have been shown to be a
sensitive marker of impaired tissue perfusion and of
anaerobic metabolism in patients with suspected sepsis,
predictive of mortality, and are a valid identification
method for patients who will benefit from early aggressive
goal-directed therapy [40]. Recent guidelines suggest
immediate targeted fluid resuscitation as a means of
normalizing lactate in these patients [41]. Rapid measure-
ment of lactate is important as elevated lactate levels have
been linked to increased mortality, with a sizable percentage
of deaths occurring within the first few days (Figure 1). The
initiation of goal-directed therapy within the first 3 to
6 hours of presentation to the ED has been found to
improve mortality rates by 16% [41,42]. Additionally,
decreases in lactate levels of 20% every 2 hours for the first
8 hours have been associated with a 9.6% reduction in
mortality [43]. Delays in triage and test processing times
because of overcrowding have the potential to significantly
delay test results and increase time-to-treatment initiation.
Valid POCT technologies for measuring whole blood and
fingertip lactate are available, providing almost immediate
feedback. One study found that POCT for fingertip lactate
during triage was associated with results being available to
physicians 151 minutes earlier than when whole-blood
lactate levels were taken at the discretion of the treatingFigure 1 Serum lactate as a predictor of mortality in emergency
department (ED) patients with sepsis. In-hospital mortality rates were
documented for patients who presented to the ED with infection, and
serum lactate measurements were available (n = 1,278). Greater 3-day
and 28-day mortality rates were found in patients with lactate levels of
more than 4.0 mmol/L. Reprinted with permission from Elsevier [46].physician [44]. This study did not evaluate medical out-
comes, but a separate study found improved outcomes in
patients with higher lactate clearance at 6 hours compared
with patients with lower clearance [45]. This relationship
between time-to-treatment initiation and patient outcome
highlights the need for expedited diagnosis through POCT.
Stroke
During recent years, thrombolysis has revolutionized the
treatment of ischemic stroke, increasing long-term
survival and reducing morbidity. Owing to an increased risk
of bleeding with delayed thrombolysis, minimizing delays
in treatment is crucial in the modern treatment of
non-hemorrhagic stroke. Reducing delays between symp-
tom onset and initiation of thrombolysis has been shown to
be a critical factor in predicting positive outcomes and
reducing overall mortality rates [47]. The immediate assess-
ment of a patient’s coagulation status (that is, international
normalized ratio, partial thromboplastin time, hemoglobin,
and platelet count) is necessary to ensure timely and safe
thrombolysis. Early computed tomography (CT) scan, CT
angiography, and diffusion-weighted imaging scanning are
also needed in order to exclude hemorrhagic stroke and to
elucidate the potential benefit of thrombolysis. Delays in
laboratory results were recently identified as one of the
major barriers to the early initiation of thrombolysis
therapy in a simulation-based approach [48], highlighting a
need for improved efficiency in testing. Several studies have
clearly shown the benefits of POCT in the management of
stroke. Results show that POCT can reduce TATs by 30 to
50 minutes and can significantly increase the incidence of
early thrombolysis, positively impacting patient care [18,49].
Challenges to effective implementation of point-of-care
testing
Important challenges exist with any significant change to
existing ED methodologies. Clinical pathways and ED
logistics may need substantial modification to maximize
the clinical and economic benefits of rapid TATs provided
by POCT. Furthermore, the direct cost per analysis for
the majority of POCT devices is higher than the cost per
analysis in centralized laboratories. In this clinical context
and with respect to the numerous manual steps to be
performed in transferring a blood sample to the central
laboratory and to retrieve the results consecutively,
the total costs of POCT devices tend not to exceed
those of central analysis. Clinical trials in academic
hospitals did not reveal clear disadvantages of POCT
versus central analysis, whereas trials in rural regions
were in favor of POCT [31,50].
Most POCT devices are operated by staff with limited
technical background. Cooperation from central laboratory
personnel is therefore essential to ensure adequate
quality of test results. Additionally, POCT places additional
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commonly perform POCT. Nurses must undergo regular
training and meet certification requirements for quality
assurance purposes, placing additional burdens on individ-
uals with an already heavy workload. On the other
hand, expediting patient flow through POCT might help
to reduce this strain on staff. Additional oversight
and regulatory challenges will exist for any substantial
implementation of POCT in the ED. These costs must
be weighed against the potential gains in efficiency
and in patient care that one can realistically expect to
gain from POCT.
These challenges can be met via internal quality
control and external quality assessment (EQA) methods.
Internal quality control methods help ensure that devices
are producing accurate and consistent results by analyzing
the output of a control sample. Device manufacturers may
provide the necessary control materials, or other control
samples can be used. Likewise, many devices offer internal
quality control functionality and may require quality
control checks to be performed and documented before
releasing patient results. If the POCT device has network
access, then quality control measurements can be inte-
grated into a central data management system. EQA uses
samples containing an unknown-to-the-operator value of
reagent received from an external source, such as from
an accredited EQA program or device manufacturer.
Additionally, the manpower challenges imposed by
POCT can largely be offset through indirect efficiency
benefits from improved patient care. A rapid turnover of
non-critical patients will help to reduce overcrowding, and
a lower incidence of critical or deteriorating patients in the
ED will free up costly time that nurses and staff would
otherwise spend attending to these high-risk patients.
Conclusions
Overcrowding represents a serious impediment to the
ability of the ED to provide the public with quality
emergency care. Prolonged waiting times and treat-
ment delays can have substantial effects on patient
satisfaction and outcomes. Increased mortality rates in
the ED suggest that overcrowding should be treated
as a serious public health concern and not solely as a
problem of departmental efficiency. Being of multifactorial
origin, overcrowding should be seen as a problem of
hospital-wide patient flow and could be influenced by
improved diagnostic protocols. Rapid TATs from
POCT represent one means by which clinical decision
making and patient management might be expedited to
counteract several of the negative effects of overcrowding
on ED performance. When used effectively and in the
appropriate context, POCT has been shown to reduce
delays to treatment initiation in the critically ill, improve
outcomes, increase timely patient discharge rates, anddecrease total length of stay. Elevated costs of POCT per
analysis seem to be outweighed by the total gain of
expedited patient flow in the appropriate setting.
Continual advances in POCT promise to broaden the
applications of this technology and provide further
opportunities to improve the quality of pre-hospital and
hospital emergency care. Developments in comprehensive
POCT technology for the complete blood count, preg-
nancy testing, infectious diseases, and cancer screening
promise to change the way emergency medicine is prac-
ticed. As technology advances and POCT devices continue
to expand their test menus and functionality, it seems
only a matter of when, and not whether, POCT becomes
commonplace in emergency medicine.
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